LORI POCETA: Open Payments
NPI 1780742387 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 29 payments from 9 companies in 2025. Trend: 2023 $704 · 2024 $560 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $272 |
| Novo Nordisk Inc | 8 | $141 |
| Madrigal Pharmaceuticals | 2 | $59 |
| Currax Pharmaceuticals LLC | 3 | $47 |
| Ascendis Pharma Endocrinology Inc | 1 | $29 |
| Abbott Laboratories | 1 | $28 |
| Radius Health, Inc. | 1 | $25 |
| VIVUS LLC | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $14 |
Products named: MOUNJARO, Wegovy, REZDIFFRA, CONTRAVE, Yorvipath, FREESTYLE LIBRE 3, QSYMIA, INSPIRE.
Industry payments across CA — which companies pay providers there.
